Alzheimer’s drug that failed early tests now dubbed effective, heads to FDA
DocuTicker DocuBase Category: GAO 2019-10-23
Summary:
An analysis in March suggested that testing the drug was futile.
Link:
https://arstechnica.com/?p=1589875From feeds:
Cyberlaw » Ars TechnicaMusic and Digital Media » Ars Technica
Berkeley Law Library -- Reference & Research Services » Ars Technica » Scientific Method